P
Pragya D Yadav
Researcher at National Institute of Virology
Publications - 262
Citations - 6207
Pragya D Yadav is an academic researcher from National Institute of Virology. The author has contributed to research in topics: Medicine & Virus. The author has an hindex of 32, co-authored 191 publications receiving 3275 citations. Previous affiliations of Pragya D Yadav include Centers for Disease Control and Prevention & Indian Council of Medical Research.
Papers
More filters
Journal Article
Re-occurrence of Crimean-Congo haemorrhagic fever in Ahmedabad, Gujarat, India (2012): a fatal case report.
TL;DR: A fatal case of CCHF is reported from Ahmadabad, Gujarat on June 21, 2012 with complaints of fever, headache, anorexia, general weakness, metallic taste in mouth since last two days, and the patient had no symptom suggestive of allergic condition, diabetes, but had past history of hepatitis E virus infection.
Journal ArticleDOI
Elevated neutralization of Omicron with sera of COVID-19 recovered and breakthrough cases vaccinated with Covaxin than two dose naïve vaccinees
Pragya D Yadav,Gajanan N. Sapkal,Rima R Sahay,Deepak P. Patil,Gururaj Rao Deshpande,Rajlaxmi Jain,Dimpal A Nyayanit,Anita M. Shete,Annasaheb Maruti Suryawanshi,Ashok Nandapurkar,Yogesh K. Gurav,Priya Abraham +11 more
TL;DR: Yang et al. as mentioned in this paper evaluated the neutralization potential of inactivated vaccines amongst breakthrough cases and vaccinees with regular and booster doses against Omicron variant and found that the vaccinees had lower neutralization.
Journal Article
Molecular characterization of Chittoor (Batai) virus isolates from India.
TL;DR: Analysis of the sequences of the S, M and L segments of genome indicated that the virus has not undergone any reassortment, indicating the presence of a single genotype of CHITV circulating in India.
Posted ContentDOI
Safety and immunogenicity trial of an inactivated SARS-CoV-2 vaccine-BBV152: a phase 1, double-blind, randomised control trial
Raches Ella,Krishna Mohan,Harsh Jogdand,Sai Prasad,Siddharth Reddy,Vamshi Sarangi,Brunda Ganneru,Gajanan Sapkal,Pragya D Yadav,Samiran Panda,Nivedita Gupta,P. Prabhakar Reddy,Savita Verma,Sanjay K Rai,Chandramani Singh,Sagar Vivek Redkar,Chandra Sekhar Gillurkar,Jitendra Singh Kushwaha,Venkat Rao,Satyajit Mohapatra,Randeep Guleria,Krishna Murthy Ella,Balram Bhargava +22 more
TL;DR: BBV152 induced binding and neutralising antibody responses and with the inclusion of the Algel-IMDG adjuvant, this is the first inactivated SARS-CoV-2 vaccine that has been reported to induce a Th1-biased response.
Journal ArticleDOI
Factors associated with mortality among moderate and severe patients with COVID-19 in India: a secondary analysis of a randomised controlled trial.
Joy John Mammen,Snehil Kumar,Lovely Thomas,Gunjan Kumar,Anand Zachariah,Lakshmanan Jeyaseelan,John Victor Peter,Anup Agarwal,Aparna Mukherjee,Pranab Chatterjee,Tarun Bhatnagar,Jess Elizabeth Rasalam,Binila Chacko,Thenmozhi Mani,Melvin Joy,Priscilla Rupali,Malathi Murugesan,Dolly Daniel,B Latha,Sunita Bundas,Vivek Kumar,Ravi Dosi,Janakkumar R Khambholja,Rosemarie de Souza,B Thrilok Chander,Shalini Bahadur,Simmi Dube,Amit Suri,Aikaj Jindal,Om Shrivastav,Vijay Barge,Archana Bajpayee,Pankaj Malhotra,Neha Singh,Muralidhar Tambe,Nimisha Sharma,Shreepad Bhat,Ram S Kaulgud,Anil Gurtoo,D. Himanshu Reddy,Kamlesh Upadhyay,Ashish Jain,Tinkal C Patel,Irfan Nagori,Pramod R Jha,KV Sreedhar Babu,C Aparna,Sunil J Panjwani,M Natarajan,Milind Baldi,Vrushali Khirid Khadke,Seema Dua,Ravindraa Singh,Ashish Sharma,Jayashree Sharma,Yojana A Gokhale,Pragya D Yadav,Gajanan N. Sapkal,Himanshu Kaushal,V Saravana Kumar +59 more
TL;DR: In this article, the authors analyzed the factors associated with mortality in a cohort of moderately and severely ill patients with COVID-19 enrolled in a randomised trial on convalescent plasma.